Telangana is pitching itself as a major Indian hub for global healthcare, life sciences and medical technology investment, with Industries Minister D. Sridhar Babu telling international delegations that the state offers strong infrastructure for advanced medical-device manufacturing and research. The minister said Telangana’s ecosystem is already equipped to support companies that want to begin production quickly, especially through assets such as the Medical Devices Park and Genome Valley.
The statement came during a series of meetings at the State Secretariat on April 21, 2026, where delegations connected to healthcare, MedTech, advanced manufacturing and research met the minister. A team of MedTech entrepreneurs and university researchers from the Netherlands also participated, led by Netherlands Innovation Councillor Jan Reint Smith.
Sridhar Babu said Telangana is well suited for medical research, artificial intelligence development and device manufacturing. He urged visiting innovators and companies to explore partnerships with local universities, indicating that the state wants to build not only factories, but also a deeper research-and-innovation pipeline around healthcare technology.
The Norwegian delegation was led by Ambassador May-Elin Stener. During the interaction, the minister described Telangana as a strong destination for investments in life sciences and healthcare, effectively positioning the state as Norway’s preferred partner in India for healthcare-related collaboration.
The meetings also included a separate delegation from Italy, led by Ambassador Antonio Bartoli. Sridhar Babu encouraged Italian industrialists to look at Telangana for investments in advanced manufacturing, showing that the state is pursuing a broader international investment strategy across Europe, not only in healthcare but also in high-value industrial sectors.
Senior Telangana officials were also present, including TGIIC Managing Director Shashank, Industries Commissioner Nikhil Chakravarthy, Special Secretary Raghurama Sharma, Telangana Life Sciences CEO Sarvesh Singh, and IT Advisor I Sai Krishna. Their presence suggests that the discussions were aimed at converting diplomatic interest into practical investment and institutional partnerships.
The significance of the outreach lies in Telangana’s attempt to combine three strengths: manufacturing-ready infrastructure, a growing life-sciences base, and university-linked innovation. For Norway, which has strong healthcare, research and medical-technology capabilities, Telangana offers an Indian platform for market access, production, AI-led healthcare applications and institutional collaboration.
Overall, the engagement reflects Telangana’s ambition to become a preferred gateway for European healthcare and MedTech companies entering India. If these discussions mature into investments or research partnerships, the state could strengthen its position as one of India’s leading centres for life sciences, medical devices and healthcare innovation.
You may also like
-
Black Pepper In Ayurveda: The Fiery Seed That Kindles Digestion, Clears Heaviness
-
Lupin Launches Generic Anti-Diabetic Tablets in US, Expands Diabetes Care Portfolio
-
Ash Gourd in Ayurveda: The Strength of Kushmanda
-
Mukkutti (Biophytum sensitivum): A Small Herb with a Big Ayurvedic Presence
-
AFMS Doctors To Practise Across India Under New NMC Draft Rules